A shadow market for unlicensed weight-loss medications is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Experimental Drug Acquiring Traction Via Social Media
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its alleged weight-reducing properties. Followers are urged to contact these profiles directly for supplier links, while also receiving discount codes.
Active Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with thousands of participants share “before and after” photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before directing customers to WhatsApp for purchases.
Learning About Retatrutide
Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The treatment targets three intestinal hormones – GLP-1, GIP and glucagon. Early trials indicate it could assist individuals reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.
Medical Professionals Voice Worries
Nevertheless, physicians and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is a cause for concern and could lead to individuals administering products of unknown origin.
Some experts stated the popularity for retatrutide could be connected to the rising price of approved weight loss treatments such as Mounjaro.
Regulatory Status and Enforcement
Marketing the unapproved drug on social media or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, advertising, and customer regulations, risking fines, legal action or prison.
Service Response and Content Removal
Based on TikTok, the platform has taken down violative material and banned related hashtags and search suggestions. The company said it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.
Digital Trading Activities
Research also found groups with up to nine thousand members selling the experimental drug using the platform's built-in search feature, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, populated with images of weight loss, positive reviews and detailed guides for preparing or administering at home.
Within moments of entering one group, a seller shared contact information, where the majority of purchases occur. The seller provided an guidebook and promised shipping within 48 hours. When asked whether the product was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. None asked about body mass, medical conditions or past usage.
Item Information and Costs
Inside these groups, messages display black plastic parcels with postal service labels, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”
Customers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens typically priced at 160 pounds for 20mg. When questioned how long a pen should be used, vendors give conflicting responses ranging from a several days to “depends on your body”.
Service Moderation and Safety Actions
A representative for Telegram said it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.
Medical Expert Cautions
“People are administering substances they can’t verify. Although the research behind retatrutide is valid, these digital versions may not include what they claim,” said Jason Murphy, the head of pharmacy at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to recent price rises for approved slimming medications such as Mounjaro. “With prices increasing, patients are using social media. But fake injections are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was sterile,” she explained.
Her team has already encountered individuals injured by personal administration from unverified sources. “We recognize the disappointment, but buying from messaging apps or WhatsApp is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they explained, noting that any product “falsely representing itself as a company experimental substance not yet approved … may expose users to potentially significant health risks”.
